H E Jenkins1, C M Yuen2. 1. Department of Biostatistics, Boston University School of Public Health, Boston. 2. Division of Global Health Equity, Brigham and Women's Hospital, Boston, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Childhood tuberculosis (TB) has historically been neglected, although in recent years there has been increased focus on this problem. In particular, there have been two efforts to estimate the burden of pediatric multidrug-resistant TB (MDR-TB). METHODS: We review current estimates of the global incidence of pediatric MDR-TB disease. We then combine pediatric MDR-TB treatment data from the World Health Organization and recently published case fatality ratio estimates for children with TB to produce mortality estimates for children with MDR-TB. Finally, we combine treatment data and estimates of household size and disease risk to estimate how many children could be treated for probable or confirmed MDR-TB by carrying out household contact investigations around adult MDR-TB patients. RESULTS: Between 25 000 and 32 000 children develop MDR-TB disease annually, accounting for around 3% of all pediatric TB cases. Only 3-4% of these children are likely to receive MDR-TB treatment. We estimate that around 21% of children who develop MDR-TB disease will die. Carrying out household contact investigations around adult MDR-TB patients could find an estimated 12 times as many pediatric MDR-TB cases as are currently being identified. DISCUSSION: The diagnosis and treatment of children with MDR-TB needs to be prioritized by TB programs.
BACKGROUND:Childhood tuberculosis (TB) has historically been neglected, although in recent years there has been increased focus on this problem. In particular, there have been two efforts to estimate the burden of pediatric multidrug-resistant TB (MDR-TB). METHODS: We review current estimates of the global incidence of pediatric MDR-TB disease. We then combine pediatric MDR-TB treatment data from the World Health Organization and recently published case fatality ratio estimates for children with TB to produce mortality estimates for children with MDR-TB. Finally, we combine treatment data and estimates of household size and disease risk to estimate how many children could be treated for probable or confirmed MDR-TB by carrying out household contact investigations around adult MDR-TB patients. RESULTS: Between 25 000 and 32 000 children develop MDR-TB disease annually, accounting for around 3% of all pediatric TB cases. Only 3-4% of these children are likely to receive MDR-TB treatment. We estimate that around 21% of children who develop MDR-TB disease will die. Carrying out household contact investigations around adult MDR-TB patients could find an estimated 12 times as many pediatric MDR-TB cases as are currently being identified. DISCUSSION: The diagnosis and treatment of children with MDR-TB needs to be prioritized by TB programs.
Authors: Ibrahim Abubakar; Matteo Zignol; Dennis Falzon; Mario Raviglione; Lucica Ditiu; Susan Masham; Ifedayo Adetifa; Nathan Ford; Helen Cox; Stephen D Lawn; Ben J Marais; Timothy D McHugh; Peter Mwaba; Matthew Bates; Marc Lipman; Lynn Zijenah; Simon Logan; Ruth McNerney; Adam Zumla; Krishna Sarda; Payam Nahid; Michael Hoelscher; Michel Pletschette; Ziad A Memish; Peter Kim; Richard Hafner; Stewart Cole; Giovanni Battista Migliori; Markus Maeurer; Marco Schito; Alimuddin Zumla Journal: Lancet Infect Dis Date: 2013-03-24 Impact factor: 25.071
Authors: Helen E Jenkins; Arielle W Tolman; Courtney M Yuen; Jonathan B Parr; Salmaan Keshavjee; Carlos M Pérez-Vélez; Marcello Pagano; Mercedes C Becerra; Ted Cohen Journal: Lancet Date: 2014-03-24 Impact factor: 79.321
Authors: Helen E Jenkins; Courtney M Yuen; Carly A Rodriguez; Ruvandhi R Nathavitharana; Megan M McLaughlin; Peter Donald; Ben J Marais; Mercedes C Becerra Journal: Lancet Infect Dis Date: 2016-12-08 Impact factor: 25.071
Authors: N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra Journal: Clin Infect Dis Date: 2013-09-24 Impact factor: 9.079
Authors: Grant Theron; Helen E Jenkins; Frank Cobelens; Ibrahim Abubakar; Aamir J Khan; Ted Cohen; David W Dowdy Journal: Lancet Date: 2015-10-26 Impact factor: 79.321
Authors: Courtney M Yuen; Farhana Amanullah; Ashwin Dharmadhikari; Edward A Nardell; James A Seddon; Irina Vasilyeva; Yanlin Zhao; Salmaan Keshavjee; Mercedes C Becerra Journal: Lancet Date: 2015-11-04 Impact factor: 202.731
Authors: Peter J Dodd; Courtney M Yuen; Mercedes C Becerra; Paul Revill; Helen E Jenkins; James A Seddon Journal: Lancet Glob Health Date: 2018-09-25 Impact factor: 26.763
Authors: Habteyes Hailu Tola; Kourosh Holakouie-Naieni; Mohammad Ali Mansournia; Mehdi Yaseri; Ephrem Tesfaye; Zemedu Mahamed; Million Molla Sisay Journal: PLoS One Date: 2020-02-26 Impact factor: 3.240
Authors: Silvia Shinpei Chiang; Yana Sheremeta; Rachel Sophie Padilla; Helen Elizabeth Jenkins; Charles Robert Horsburgh; Vasyl Petrenko; Natasha Renee Rybak Journal: J Epidemiol Glob Health Date: 2019-03
Authors: R Moodliar; V Aksenova; M V G Frias; J van de Logt; S Rossenu; E Birmingham; S Zhuo; G Mao; N Lounis; C Kambili; N Bakare Journal: Int J Tuberc Lung Dis Date: 2021-09-01 Impact factor: 2.373